Economy · Full coverage
Israeli Weight Loss Pill Company Stock Soars After New CEO Appointment
How 2 Israeli newsrooms covered this story — translated into English and compared side by side.
Center 1Unrated 1
By נווית זומר
First reported by Bizportal · 10 hours ago
What happened
Epitomee, an Israeli weight loss pill company, saw its stock surge over 110% in three days following the appointment of a new CEO with a strong rehabilitation track record. The company aims to capture a significant share of the weight loss market with its FDA-approved, swallowable device.
- 01Epitomee's stock price jumped over 110% in three days.
- 02The surge follows the appointment of new CEO Dolev Refaeli.
- 03The company's product is a swallowable weight loss pill.
- 04The pill is FDA-approved and aims to create a feeling of fullness.
- 05Epitomee plans direct-to-consumer marketing in the U.S.
Summary translated & synthesized from the sources below by baba. Read each original for the full report.
Full coverage · 2 outlets
The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.
Related stories
Israeli Weight-Loss Pill Developer Appoints New CEO to Revive Struggling CompanyAug 12, 2026Israeli Regulator Fines Medical Company and Executives for Misleading ReportsSep 1, 2026New Oral Weight Loss Pill Launches in Israel, Offering Injection-Free Alternative3 days agoEli Lilly Launches New GLP-1 Weight-Loss Pill in Israel3 days agoIsraeli Companies Announce Medical Breakthroughs and Investments6 days agoNew Oral Weight-Loss Pill Approved for Sale in Israel2 days ago